Acyclovir
Product Images NDC 52959-517
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 52959-517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Acyclovir Capsules 200 mg 100s Label (4653f43f B62a 45c2 Bfad Afee9fdc2e12 04)
This is a description of a drug product identified as 52959-517-30. The product is ACYCLOVIR 200mg capsules manufactured in Toronto, Canada by TEVA PHARM. The lot number and expiry date are ACY200TV and 02/12, respectively. The capsules are RX only and are intended for use to treat a condition similar to Zovirax. The package has a pill identifier for the blue capsule. The dosage should be taken as prescribed by a doctor or by following the usual dosing information found in the outsert provided. There is a caution note which seems to mention allergies "CAUTION. et PROMENS e orr o 1 o oo e e e s o s X i KEP SUPS AR AR S T Gagroe." The rest of the text appears to be lot numbers and codes related to the product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.